A randomised controlled trial of ranibizumab with and without ketorolac eyedrops for exudative age-related macular degeneration
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A randomised controlled trial of ranibizumab with and without ketorolac eyedrops for exudative age-related macular degeneration
Authors
Keywords
-
Journal
BRITISH JOURNAL OF OPHTHALMOLOGY
Volume 97, Issue 10, Pages 1273-1276
Publisher
BMJ
Online
2013-07-20
DOI
10.1136/bjophthalmol-2013-303417
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PHARMACOKINETIC COMPARISON OF KETOROLAC AFTER INTRACAMERAL, INTRAVITREAL, AND SUPRACHOROIDAL ADMINISTRATION IN RABBITS
- (2012) MeiZi Wang et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- TOPICAL BROMFENAC AS AN ADJUNCTIVE TREATMENT WITH INTRAVITREAL RANIBIZUMAB FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION
- (2012) Fumi Gomi et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Prostaglandin E2 Inhibition of Ketorolac 0.45%, Bromfenac 0.09%, and Nepafenac 0.1% in Patients Undergoing Phacoemulsification
- (2011) Frank A. Bucci et al. ADVANCES IN THERAPY
- Cytokines in neovascular age-related macular degeneration: fundamentals of targeted combination therapy
- (2011) J. R. de Oliveira Dias et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- A randomized comparison of to-aqueous penetration of ketorolac 0.45%, bromfenac 0.09% and nepafenac 0.1% in cataract patients undergoing phacoemulsification
- (2011) Frank A. Bucci et al. CURRENT MEDICAL RESEARCH AND OPINION
- ASSOCIATION BETWEEN FOVEAL MICROSTRUCTURE AND VISUAL OUTCOME IN AGE-RELATED MACULAR DEGENERATION
- (2011) Hyun Jin Shin et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- PROSPECTIVE RANDOMIZED CONTROLLED TRIAL OF COMBINATION RANIBIZUMAB (LUCENTIS) AND BROMFENAC (XIBROM) FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
- (2011) Christina Flaxel et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Inhibition of Choroidal Neovascularization by Intravitreal Ketorolac
- (2010) Stephen J. Kim ARCHIVES OF OPHTHALMOLOGY
- Comparison of two intravitreal ranibizumab treatment schedules for neovascular age-related macular degeneration
- (2010) B. Gupta et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Ketorolac inhibits choroidal neovascularization by suppression of retinal VEGF
- (2010) Stephen J. Kim et al. EXPERIMENTAL EYE RESEARCH
- Genetic deletion of COX-2 diminishes VEGF production in mouse retinal Müller cells
- (2010) Susan E. Yanni et al. EXPERIMENTAL EYE RESEARCH
- Nonsteroidal Anti-inflammatory Drugs in Ophthalmology
- (2010) Stephen J. Kim et al. SURVEY OF OPHTHALMOLOGY
- VITREOUS NONSTEROIDAL ANTIINFLAMMATORY DRUG CONCENTRATIONS AND PROSTAGLANDIN E2 LEVELS IN VITRECTOMY PATIENTS TREATED WITH KETOROLAC 0.4%, BROMFENAC 0.09%, AND NEPAFENAC 0.1%
- (2009) JEFFREY S. HEIER et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study
- (2008) David M. Brown et al. OPHTHALMOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started